Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target

Why Do Cancers Have High Aerobic Glycolysis?

Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784

The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation

DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppé, J., Tong, F. K., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.008 · Cited by 3,224

Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis

Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941

Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis

DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

Prat, A., Parker, J. S., Karginova, O. A., Fan, C., Livasy, C., Herschkowitz, J. I., He, X., & Perou, C. M. (2010) · Breast Cancer Research · doi:10.1186/bcr2635 · Cited by 2,290

c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism

Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124

Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction

Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001

Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy

Nicklin, P., Bergman, P., Zhang, B., Triantafellow, E., Wang, H., Nyfeler, B., Yang, H., Hild, M., Kung, C., Wilson, C., et al. (2009) · Cell · doi:10.1016/j.cell.2008.11.044 · Cited by 1,798

Glutamine addiction: a new therapeutic target in cancer

Wise, D. R., & Thompson, C. B. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.05.003 · Cited by 1,770

Nitrogen Metabolism in Cancer and Immunity

Kurmi, K., & Haigis, M. C. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.02.005 · Cited by 167

ATF4 and N‐Myc coordinate glutamine metabolism in MYCN ‐amplified neuroblastoma cells through ASCT2 activation

Ren, P., Yue, M., Xiao, D., Xiu, R., Gan, L., Liu, H., & Qing, G. (2014) · The Journal of Pathology · doi:10.1002/path.4429 · Cited by 157

The crosstalk between autophagy and ferroptosis: what can we learn to target drug resistance in cancer?

Zhou, Y., Shen, Y., Chen, C., Sui, X., Yang, J., Wang, L., & Zhou, J. (2019) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2019.0158 · Cited by 157

RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translation

Jones, R. A., Robinson, T., Liu, J. C., Shrestha, M., Voisin, V., Ju, Y., Chung, P. E. D., Pellecchia, G., Fell, V. L., Bae, S., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci81568 · Cited by 148

Exploiting Metabolic Vulnerabilities of Cancer with Precision and Accuracy

Wolpaw, A. J., & Dang, C. V. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.11.006 · Cited by 151

Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies

Liao, M., Qin, R., Huang, W., Zhu, H.-P., Peng, F., Han, B., & Liu, B. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01260-0 · Cited by 149

Mitochondrial OXPHOS Induced by RB1 Deficiency in Breast Cancer: Implications for Anabolic Metabolism, Stemness, and Metastasis

Zacksenhaus, E., Shrestha, M., Liu, J. C., Vorobieva, I., Chung, P. E. D., Ju, Y., Nir, U., & Jiang, Z. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.09.002 · Cited by 143

Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer

Morotti, M., Bridges, E., Valli, A., Choudhry, H., Sheldon, H., Wigfield, S., Gray, N., Zois, C. E., Grimm, F., Jones, D., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1818521116 · Cited by 131

Glutamine metabolism in breast cancer and possible therapeutic targets

Li, S., Zeng, H., Fan, J., Wang, X., Xu, C., Li, Y., Tu, J., Nephew, K. P., & Long, X. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115464 · Cited by 143

Alternative fuels for cancer cells

Keenan, M. M., & Chi, J.-T. (2015) · The Cancer Journal · doi:10.1097/ppo.0000000000000104 · Cited by 131

Glutamate enrichment as new diagnostic opportunity in breast cancer

Budczies, J., Pfitzner, B. M., Győrffy, B., Winzer, K., Radke, C., Dietel, M., Fiehn, O., & Denkert, C. (2014) · International Journal of Cancer · doi:10.1002/ijc.29152 · Cited by 133

Amino acid transporter SLC6A14 is a novel and effective drug target for pancreatic cancer

Coothankandaswamy, V., Cao, S., Xu, Y., Prasad, P. D., Singh, P. K., Reynolds, C. P., Yang, S., Ogura, J., Ganapathy, V., & Bhutia, Y. D. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13616 · Cited by 132

Identification of metabolic vulnerabilities of receptor tyrosine kinases-driven cancer

Jin, N., Bi, A., Lan, X., Xu, J., Wang, X., Liu, Y., Wang, T., Tang, S., Zeng, H., Chen, Z., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10427-2 · Cited by 129

Regulation of antioxidants in cancer

Hecht, F., Zocchi, M., Alimohammadi, F., & Harris, I. S. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.11.001 · Cited by 138

Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer

Morotti, M., Zois, C. E., Ansari, R. E., Craze, M. L., Rakha, E. A., Fan, S., Valli, A., Haider, S. A., Goberdhan, D. C. I., Green, A. R., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01113-y · Cited by 134

Temozolomide toxicity operates in a xCT/SLC7a11 dependent manner and is fostered by ferroptosis

Sehm, T., Rauh, M., Wiendieck, K., Buchfelder, M., Eyüpoglu, I. Y., & Savaskan, N. E. (2016) · Oncotarget · doi:10.18632/oncotarget.11858 · Cited by 129

Post-translational modifications reshape the antigenic landscape of the MHC I immunopeptidome in tumors

Kacen, A., Javitt, A., Kramer, M. P., Morgenstern, D., Tsaban, T., Shmueli, M. D., Teo, G. C., Leprevost, F. D. V., Barnea, E., Yu, F., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01464-2 · Cited by 129

Immunotargeting of Antigen xCT Attenuates Stem-like Cell Behavior and Metastatic Progression in Breast Cancer

Lanzardo, S., Conti, L., Rooke, R., Ruiu, R., Accart, N., Bolli, E., Arigoni, M., Macagno, M., Barrera, G., Pizzimenti, S., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1208 · Cited by 130

SLC7A11/ xCT is a target of miR-5096 and its restoration partially rescues miR-5096-mediated ferroptosis and anti-tumor effects in human breast cancer cells

Yadav, P., Sharma, P., Sundaram, S., Venkatraman, G., Bera, A. K., & Karunagaran, D. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.09.033 · Cited by 127

Inhibition of xCT suppresses the efficacy of anti-PD-1/L1 melanoma treatment through exosomal PD-L1-induced macrophage M2 polarization

Liu, N., Zhang, J., Yin, M., Liu, H., Zhang, X., Li, J., Yan, B., Guo, Y., Zhou, J., Tao, J., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.03.013 · Cited by 130

The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids

McAllister, S. D., Soroceanu, L., & Desprez, P. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9608-y · Cited by 144

Pyruvate carboxylase and cancer progression

Kiesel, V. A., Sheeley, M. P., Coleman, M. F., Kulkoyluoglu‐Cotul, E., Donkin, S. S., Hursting, S. D., Wendt, M. K., & Teegarden, D. (2021) · Cancer & Metabolism · doi:10.1186/s40170-021-00256-7 · Cited by 131

Identification of structurally diverse FSP1 inhibitors that sensitize cancer cells to ferroptosis

Hendricks, J. M., Doubravsky, C. E., Wehri, E., Li, Z., Roberts, M. A., Deol, K. K., Lange, M., Lasheras-Otero, I., Momper, J. D., Dixon, S. J., et al. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.04.007 · Cited by 129

Microenvironmental regulation of cancer cell metabolism: implications for experimental design and translational studies

Muir, A., Danai, L. V., & Heiden, M. G. V. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.035758 · Cited by 124

Overview of the Development of Glutaminase Inhibitors: Achievements and Future Directions

Xu, X. J., Meng, Y., Li, L., Xu, P., Wang, J., Li, Z., & Bian, J. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00961 · Cited by 118

SLC transporters as a novel class of tumour suppressors: identity, function and molecular mechanisms

Bhutia, Y. D., Babu, E., Ramachandran, S., Yang, S., Thangaraju, M., & Ganapathy, V. (2016) · Biochemical Journal · doi:10.1042/bj20150751 · Cited by 118

Metabolic Regulation of Redox Balance in Cancer

Purohit, V., Simeone, D. M., & Lyssiotis, C. A. (2019) · Cancers · doi:10.3390/cancers11070955 · Cited by 121

Ferroptosis: An emerging therapeutic opportunity for cancer

Wang, L., Chen, X., & Yan, C. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.09.005 · Cited by 120

Organ-Specific Cancer Metabolism and Its Potential for Therapy

Elia, I., Schmieder, R., Christen, S., & Fendt, S. (2015) · Handbook of experimental pharmacology · doi:10.1007/164_2015_10 · Cited by 112

Interleukin-6 facilitates tumor progression by inducing ferroptosis resistance in head and neck squamous cell carcinoma

Li, M. K., Jin, S., Zhang, Z., Ma, H., & Yang, X. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.12.011 · Cited by 121

Ferroptosis‐modulating small molecules for targeting drug‐resistant cancer: Challenges and opportunities in manipulating redox signaling

Koeberle, S. C., Kipp, A. P., Stuppner, H., & Koeberle, A. (2023) · Medicinal Research Reviews · doi:10.1002/med.21933 · Cited by 117

The EGF Receptor Promotes the Malignant Potential of Glioma by Regulating Amino Acid Transport System xc( — )

Tsuchihashi, K., Okazaki, S., Ohmura, M., Ishikawa, M., Sampetrean, O., Onishi, N., Wakimoto, H., Yoshikawa, M., Seishima, R., Iwasaki, Y., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2121 · Cited by 114

Metabolic Alterations Caused by KRAS Mutations in Colorectal Cancer Contribute to Cell Adaptation to Glutamine Depletion by Upregulation of Asparagine Synthetase

Toda, K., Kawada, K., Iwamoto, M., Inamoto, S., Sasazuki, T., Shirasawa, S., Hasegawa, S., & Sakai, Y. (2016) · Neoplasia · doi:10.1016/j.neo.2016.09.004 · Cited by 113

Role and regulation of coordinately expressedde novopurine biosynthetic enzymesPPATandPAICSin lung cancer

Goswami, M. T., Chen, G., Chakravarthi, B. V. S. K., Pathi, S. S., Anand, S. K., Carskadon, S. L., Giordano, T. J., Chinnaiyan, A. M., Thomas, D. G., Palanisamy, N., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4352 · Cited by 118

AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancer

Kubli, S. P., Bassi, C., Roux, C., Wakeham, A. C., Göbl, C., Zhou, W., Jafari, S. M., Snow, B. E., Jones, L., Palomero, L., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1815126116 · Cited by 116

Proteomic Screens for Suppressors of Anoikis Identify IL1RAP as a Promising Surface Target in Ewing Sarcoma

Zhang, H., Hughes, C. S., Li, W., He, J., Surdez, D., El-Naggar, A. M., Cheng, H., Prudova, A., Delaidelli, A., Negri, G. L., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1690 · Cited by 111

Combined deletion of Pten and p53 in mammary epithelium accelerates triple‐negative breast cancer with dependency on eEF2K

Liu, J. C., Voisin, V., Wang, S., Wang, D., Jones, R. A., Datti, A., Uehling, D., Al‐awar, R., Egan, S. E., Bader, G. D., et al. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201404402 · Cited by 110

Starve Cancer Cells of Glutamine: Break the Spell or Make a Hungry Monster?

Jiang, J., Srivastava, S., & Zhang, J. (2019) · Cancers · doi:10.3390/cancers11060804 · Cited by 108

Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients

Liu, G., Zhu, J., Yu, M., Cai, C., Zhou, Y., Yu, M., Fu, Z., Gong, Y., Yang, B., Li, Y., et al. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0500-6 · Cited by 104

DDR2 upregulation confers ferroptosis susceptibility of recurrent breast tumors through the Hippo pathway

Lin, C., Yang, W., Lin, Y.-T., Tang, X., Chen, P., Ding, C. C., Qu, D. C., Alvarez, J. V., & Chi, J. (2021) · Oncogene · doi:10.1038/s41388-021-01676-x · Cited by 108

The Hallmarks of Cancer from a Redox Perspective

Hornsveld, M., & Dansen, T. B. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6580 · Cited by 105

MiR-27a-3p Promotes Non-Small Cell Lung Cancer Through SLC7A11-Mediated-Ferroptosis

Lu, X., Kang, N., Ling, X.-X., Pan, M., Du, W., & Gao, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.759346 · Cited by 104

Glycosylation of KEAP1 links nutrient sensing to redox stress signaling

Chen, P., Smith, T. J., Wu, J., Siesser, P. F., Bisnett, B. J., Khan, F., Hogue, M., Soderblom, E. J., Tang, F., Marks, J. R., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201696113 · Cited by 105

Glutaminolysis drives membrane trafficking to promote invasiveness of breast cancer cells

Dornier, E., Rabas, N., Mitchell, L. E., Novo, D., Dhayade, S., Marco, S., Mackay, G., Sumpton, D. P., Pallarès-Masmitjà, M., Nixon, C., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02101-2 · Cited by 102

Non-Small-Cell Lung Cancer Signaling Pathways, Metabolism, and PD-1/PD-L1 Antibodies

Santarpía, M., Aguilar, A., CHAIB-OUKADOUR, I., Cardona, A. F., Fancelli, S., Laguía, F., Bracht, J. W. P., Cao, P., Molina‐Vila, M. Á., Karachaliou, N., et al. (2020) · Cancers · doi:10.3390/cancers12061475 · Cited by 102

Magnetic nanoparticles for ferroptosis cancer therapy with diagnostic imaging

Ko, M. J., Min, S., Hong, H., Yoo, W., Joo, J., Zhang, Y. S., Kang, H., & Kim, D. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.09.015 · Cited by 101

[18F](2 S ,4 R )4-Fluoroglutamine PET Detects Glutamine Pool Size Changes in Triple-Negative Breast Cancer in Response to Glutaminase Inhibition

Zhou, R., Pantel, A. R., Li, S., Lieberman, B. P., Plöessl, K., Choi, H., Blankemeyer, E. R., Lee, H. S., Kung, H. F., Mach, R. H., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1945 · Cited by 99

Comprehensive Profiling of Amino Acid Response Uncovers Unique Methionine-Deprived Response Dependent on Intact Creatine Biosynthesis

Tang, X., Keenan, M. M., Wu, J., Lin, C.-A., Dubois, L. G., Thompson, J. W., Freedland, S. J., Murphy, S. K., & Chi, J. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005158 · Cited by 95

A synthetic lethal drug combination mimics glucose deprivation–induced cancer cell death in the presence of glucose

Joly, J. H., Delfarah, A., Phung, P. S., Parrish, S., & Graham, N. A. (2020) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)49891-7 · Cited by 97

Discovery of Novel Potent Covalent Glutathione Peroxidase 4 Inhibitors as Highly Selective Ferroptosis Inducers for the Treatment of Triple-Negative Breast Cancer

Chen, T., Leng, J., Tan, J., Zhao, Y., Xie, S., Zhao, S., Yan, X., Zhu, L., Luo, J., Kong, L., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00967 · Cited by 102

Glutamine Metabolism in Brain Tumors

Natarajan, S. K., & Venneti, S. (2019) · Cancers · doi:10.3390/cancers11111628 · Cited by 99

Nuclear Factor Erythroid 2-Related Factor 2 in Regulating Cancer Metabolism

Smolková, K., Mikó, E., Kovàcs, T., Leguina‐Ruzzi, A., Sipos, A., & Bai, P. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8024 · Cited by 101

Glutamine addiction in tumor cell: oncogene regulation and clinical treatment

Li, X., Peng, X., Li, Y., Wei, S., He, G., Liu, J., Li, X., Yang, S., Dai, L., Lin, W., et al. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01449-x · Cited by 103

Altered glutamine metabolism in platinum resistant ovarian cancer

Hudson, C. D., Savadelis, A., Nagaraj, A. B., Joseph, P. L., Avril, S., DiFeo, A. V., & Avril, N. E. (2016) · Oncotarget · doi:10.18632/oncotarget.9317 · Cited by 95

Glutamine‐utilizing transaminases are a metabolic vulnerability of TAZ/YAP‐activated cancer cells

Yang, C., Stampouloglou, E., Kingston, N. M., Zhang, L., Monti, S., & Varelas, X. (2018) · EMBO Reports · doi:10.15252/embr.201643577 · Cited by 97

Mitochondrial and metabolic alterations in cancer cells

Gregorio, J. D., Petricca, S., Iorio, R., Toniato, E., & Flati, V. (2022) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2022.151225 · Cited by 97

Mitochondrial dysfunction enhances cisplatin resistance in human gastric cancer cells via the ROS-activated GCN2-eIF2α-ATF4-xCT pathway

Wang, S., Chen, M.-S., Chou, Y., Ueng, Y., Yin, P., Yeh, T.-S., & Lee, H. (2016) · Oncotarget · doi:10.18632/oncotarget.12356 · Cited by 93

A Critical Role of Glutamine and Asparagine γ-Nitrogen in Nucleotide Biosynthesis in Cancer Cells Hijacked by an Oncogenic Virus

Zhu, Y., Li, T., da Silva, S. R., Lee, J. J., Lu, C., Eoh, H., Jung, J. U., & Gao, S. (2017) · mBio · doi:10.1128/mbio.01179-17 · Cited by 92

Deletion of the amino acid transporter Slc6a14 suppresses tumour growth in spontaneous mouse models of breast cancer

Babu, E., Bhutia, Y. D., Ramachandran, S., Gnana‐Prakasam, J. P., Prasad, P. D., Thangaraju, M., & Ganapathy, V. (2015) · Biochemical Journal · doi:10.1042/bj20150437 · Cited by 90

LncRNA TUG1 sponges miR-145 to promote cancer progression and regulate glutamine metabolism via Sirt3/GDH axis

Zeng, B., Ye, H., Chen, J., Cheng, D., Cai, C., Chen, G., Chen, X., Xin, H., Tang, C., & Zeng, J. (2017) · Oncotarget · doi:10.18632/oncotarget.21922 · Cited by 89

Pan-Cancer Metabolic Signature Predicts Co-Dependency on Glutaminase and De Novo Glutathione Synthesis Linked to a High-Mesenchymal Cell State

Daemen, A., Liu, B., Song, K., Kwong, M., Gao, M., Hong, R., Nannini, M., Peterson, D., Liederer, B. M., de la Cruz, C., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.06.003 · Cited by 88

Dual inhibition of glutaminase and carnitine palmitoyltransferase decreases growth and migration of glutaminase inhibition–resistant triple-negative breast cancer cells

dos Reis, L. M., Adamóski, D., Souza, R. O. O., Ascenção, C. F. R., de Oliveira, K. R. S., Corrêa‐da‐Silva, F., Patroni, F. M. D. S., Dias, M. M., Consonni, S. R., Moraes‐Vieira, P. M., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008180 · Cited by 88

Glutamine as an Essential Amino Acid for KRas-Driven Cancer Cells

Bernfeld, E., & Foster, D. A. (2019) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2019.03.003 · Cited by 85

Cystine addiction of triple-negative breast cancer associated with EMT augmented death signaling

Tang, X., Ding, C.-K., Wu, J., Sjol, J., Wardell, S. E., Spasojević, I., George, D. J., McDonnell, D. P., Hsu, D. S., Chang, J. T., et al. (2016) · Oncogene · doi:10.1038/onc.2016.394 · Cited by 86

The branched-chain amino acid transaminase 1 sustains growth of antiestrogen-resistant and ERα-negative breast cancer

Thewes, V., Simon, R., Hlevnjak, M., Schlotter, M., Schroeter, P., Schmidt, K. V., Wu, Y., Anzeneder, T., Wang, W., Windisch, P. Y., et al. (2017) · Oncogene · doi:10.1038/onc.2017.32 · Cited by 90

A synthetic lethal drug combination mimics glucose deprivation–induced cancer cell death in the presence of glucose

Joly, J. H., Delfarah, A., Phung, P. S., Parrish, S., & Graham, N. A. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011471 · Cited by 88

Amino acid transporters as emerging therapeutic targets in cancer

Saito, Y., & Soga, T. (2021) · Cancer Science · doi:10.1111/cas.15006 · Cited by 86

Targeting extracellular nutrient dependencies of cancer cells

García‐Bermúdez, J., Williams, R. T., Guarecuco, R., & Birsoy, K. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.11.011 · Cited by 93

Glutaminolysis‐related genes determine sensitivity to xCT‐targeted therapy in head and neck squamous cell carcinoma

Okazaki, S., Umene, K., Yamasaki, J., Suina, K., Otsuki, Y., Yoshikawa, M., Minami, Y., Masuko, T., Kawaguchi, S., Nakayama, H., et al. (2019) · Cancer Science · doi:10.1111/cas.14182 · Cited by 85

Cystine Deprivation Triggers Programmed Necrosis in VHL-Deficient Renal Cell Carcinomas

Tang, X., Wu, J., Ding, C. C., Lu, M., Keenan, M. M., Lin, C., Lin, C.-A., Wang, C. C., George, D. J., Hsu, D. S., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2328 · Cited by 81

Metabolic Reprogramming of Non-Hodgkin's B-Cell Lymphomas and Potential Therapeutic Strategies

Ricci, J., & Chiche, J. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00556 · Cited by 87

The Role of SLC7A11 in Cancer: Friend or Foe?

Li, S., Lu, Z., Sun, R., Guo, S., Gao, F., Cao, B., & Aa, J. (2022) · Cancers · doi:10.3390/cancers14133059 · Cited by 87

The amino acid transporter SLC6A14 in cancer and its potential use in chemotherapy

Bhutia, Y. D., Babu, E., Prasad, P. D., & Ganapathy, V. (2014) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2014.04.004 · Cited by 82

Metabolic Signature of Warburg Effect in Cancer: An Effective and Obligatory Interplay between Nutrient Transporters and Catabolic/Anabolic Pathways to Promote Tumor Growth

Mathew, M., Nguyen, N. T. H., Bhutia, Y. D., Sivaprakasam, S., & Ganapathy, V. (2024) · Cancers · doi:10.3390/cancers16030504 · Cited by 84

Hydrogen sulfide-mediated persulfidation regulates homocysteine metabolism and enhances ferroptosis in non-small cell lung cancer

Zheng, H., Chen, H., Cai, Y., Shen, M., Li, X., Han, Y., Deng, X., Cao, H., Liu, J., Li, H., et al. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.08.035 · Cited by 84

Recurrent patterns of DNA copy number alterations in tumors reflect metabolic selection pressures

Graham, N. A., Minasyan, A., Lomova, A., Cass, A. A., Balanis, N. G., Friedman, M., Chan, S. T., Zhao, S. R., Delgado, A., Go, J. L., et al. (2017) · Molecular Systems Biology · doi:10.15252/msb.20167159 · Cited by 78

The role of glutamate receptors in the regulation of the tumor microenvironment

Koda, S., Hu, J., Ju, X., Sun, G., Shao, S., Tang, R., Zheng, K., & Yan, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1123841 · Cited by 81

Hypoxia optimises tumour growth by controlling nutrient import and acidic metabolite export

Parks, S. K., Cormerais, Y., Marchiq, I., & Pouysségur, J. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2015.12.001 · Cited by 80

Hypoxia-inducible factors enhance glutamate signaling in cancer cells

Hu, H., Takano, N., Xiang, L., Gilkes, D. M., Luo, W., & Semenza, G. L. (2014) · Oncotarget · doi:10.18632/oncotarget.2593 · Cited by 76

Accelerated lipid catabolism and autophagy are cancer survival mechanisms under inhibited glutaminolysis

Halama, A., Kuliński, M., Dib, S. S., Zaghlool, S. B., Siveen, K. S., Iskandarani, A., Zierer, J., Prabhu, K. S., Satheesh, N. J., Bhagwat, A. M., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.05.017 · Cited by 75

Reprogramming of Amino Acid Metabolism in Pancreatic Cancer: Recent Advances and Therapeutic Strategies

Xu, R., Yang, J., Ren, B., Wang, H., Yang, G., Chen, Y., You, L., & Zhao, Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.572722 · Cited by 74

Fe(II) and Tannic Acid-Cloaked MOF as Carrier of Artemisinin for Supply of Ferrous Ions to Enhance Treatment of Triple-Negative Breast Cancer

Li, Z., Wu, X., Wang, W., Gai, C., Zhang, W., Li, W., & Ding, D. (2021) · Nanoscale Research Letters · doi:10.1186/s11671-021-03497-z · Cited by 74

xCT inhibition sensitizes tumors to γ-radiation via glutathione reduction

Cobler, L., Zhang, H., Suri, P., Park, C., & Timmerman, L. (2018) · Oncotarget · doi:10.18632/oncotarget.25794 · Cited by 75

Metabolic signatures of human breast cancer

Mishra, P., & Ambs, S. (2015) · Molecular & Cellular Oncology · doi:10.4161/23723556.2014.992217 · Cited by 70

DLST-dependence dictates metabolic heterogeneity in TCA-cycle usage among triple-negative breast cancer

Shen, N., Korm, S., Karantanos, T., Li, D., Zhang, X., Ritou, E., Xu, H., Lam, A., English, J., Zong, W., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02805-8 · Cited by 72

Collecting duct carcinoma of the kidney is associated withCDKN2Adeletion andSLCfamily gene up-regulation

Wang, J., Papanicolau‐Sengos, A., Chintala, S., Wei, L., Liu, B., Hu, Q., Miles, K. M., Conroy, J. M., Glenn, S. T., Costantini, M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9093 · Cited by 69

The down-regulation of SLC7A11 enhances ROS induced P-gp over-expression and drug resistance in MCF-7 breast cancer cells

Ge, C., Cao, B., Dong, F., Zhou, F., Zhang, J., Yang, N., Feng, S., Wang, G., & Aa, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-03881-9 · Cited by 69

Small-Molecule Ferroptotic Agents with Potential to Selectively Target Cancer Stem Cells

Taylor, W. R., Fedorka, S. R., Gad, I., Shah, R. V., Alqahtani, H. D., Koranne, R., Kuganesan, N., Dlamini, S., Rogers, T., Al-Hamashi, A. A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-42251-5 · Cited by 71

xCT (SLC7A11) expression confers intrinsic resistance to physical plasma treatment in tumor cells

Bekeschus, S., Eisenmann, S., Sagwal, S. K., Bodnar, Y., Moritz, J., Poschkamp, B., Stoffels, I., Emmert, S., Madesh, M., Weltmann, K., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2019.101423 · Cited by 70

The ‘Achilles Heel’ of Metabolism in Renal Cell Carcinoma: Glutaminase Inhibition as a Rational Treatment Strategy

Hoerner, C. R., Chen, V. J., & Fan, A. C. (2019) · Kidney Cancer · doi:10.3233/kca-180043 · Cited by 68

GLS2 is protumorigenic in breast cancers

Dias, M. M., Adamóski, D., dos Reis, L. M., Ascenção, C. F. R., de Oliveira, K. R. S., Mafra, A. C. P., Bastos, A. C. D. S., Quintero, M., Cassago, C. A. D. G., Ferreira, I. M., et al. (2019) · Oncogene · doi:10.1038/s41388-019-1007-z · Cited by 68

Ferroptosis: a promising target for cancer immunotherapy.

Sun, L.-L., Linghu, D.-L., & Hung, M. (2021) · PubMed · Cited by 74

The amino acid transporter SLC7A11-mediated crosstalk implicated in cancer therapy and the tumor microenvironment

He, J., Wang, X., Chen, K., Zhang, M., & Wang, J. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115241 · Cited by 70

Attenuation of Antioxidant Capacity in Human Breast Cancer Cells by Carbon Monoxide through Inhibition of Cystathionine β-Synthase Activity: Implications in Chemotherapeutic Drug Sensitivity

Kawahara, B., Moller, T., Hu-Moore, K., Carrington, S. J., Faull, K. F., Sen, S., & Mascharak, P. K. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00476 · Cited by 69

Cell death pathologies: targeting death pathways and the immune system for cancer therapy

Pentimalli, F., Grelli, S., Daniele, N. D., Melino, G., & Amelio, I. (2018) · Genes and Immunity · doi:10.1038/s41435-018-0052-x · Cited by 69

Ferroptosis-related small-molecule compounds in cancer therapy: Strategies and applications

Yin, L., Liu, P., Jin, Y., Ning, Z., Yang, Y., & Gao, H. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114861 · Cited by 66

Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer

Grinde, M. T., Hilmarsdóttir, B., Tunset, H. M., Henriksen, I. M., Kim, J., Haugen, M. H., Rye, M. B., Mælandsmo, G. M., & Moestue, S. A. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1141-0 · Cited by 65

Doxorubicin and erastin co-loaded hydroxyethyl starch-polycaprolactone nanoparticles for synergistic cancer therapy

Chen, X., Li, S., Chen, J., Wang, H., Li, Z., Deng, Q., Li, J., Wang, X., Xiong, Y., Zhang, Z., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.03.001 · Cited by 68

IGF-I Regulates Redox Status in Breast Cancer Cells by Activating the Amino Acid Transport Molecule xC−

Yang, Y., & Yee, D. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1803 · Cited by 68

Molecular targeting of glutaminase sensitizes ovarian cancer cells to chemotherapy

Masamha, C. P., & LaFontaine, P. R. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26814 · Cited by 66

Abstract B20: Glutamine metabolic vulnerabilities define triple-negative from luminal A breast cancer subsets

van Geldermalsen, M., Quek, L., Turner, N. A., Balaban, S., Hoy, A. J., Wang, Q., & Holst, J. (2018) · Molecular Cancer Research · doi:10.1158/1557-3125.advbc17-b20

Targeting xCT with sulfasalazine suppresses triple-negative breast cancer growth via inducing autophagy and coordinating cell cycle and proliferation

Long, Y., Xu, Z., Yu, J., Hu, X., Xie, Y., Duan, X., Li, N., Yan, Y., Wang, Y., & Qin, J. (2024) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000001630 · Cited by 9

Abstract P3-02-09: Vulnerabilities in glutamine metabolism define triple-negative from Luminal A breast cancer subsets

van Geldermalsen, M., Quek, L., Turner, N. A., Balaban, S., Hoy, A. J., Pang, A., Guan, Y. F., Wahi, K., Wang, Q., & Holst, J. (2020) · Cancer Research · doi:10.1158/1538-7445.sabcs19-p3-02-09

Targeting the ASCT2 glutamine uptake and metabolism pathway in triple-negative breast cancer

van Geldermalsen, M., Wang, Q., Bailey, C. G., Feng, Y., Nagarajah, R., Marshall, A. D., Thoeng, A., O’Toole, S. A., Rasko, J. E. J., & Holst, J. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv121.04

Glutamine Transporter Expression Profiling in Murine Breast Cancer Reveals Therapeutic Targets for Triple Negative Breast Cancer

Kron, C., & Bode, B. P. (2017) · The FASEB Journal · doi:10.1096/fasebj.31.1_supplement.809.6